The trading price of CERo Therapeutics Holdings Inc (NASDAQ:CERO) floating lower at last check on current market day and closing at $0.24, -1.13% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $0.2251 and $0.2556. In examining the 52-week price action we see that the stock hit a 52-week high of $12.80 and a 52-week low of $0.06. Over the past month, the stock has gained 172.73% in value.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CERo Therapeutics Holdings Inc, whose market valuation is $35.62 million at the time of this writing, is expected to release its quarterly earnings report in December. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest CERO has a Hold on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 50% Sell.
A quick review shows that CERO’s price is currently 79.47% off the SMA20 and 117.53% off the SMA50. The RSI metric on the 14-day chart is currently showing 63.99, and weekly volatility stands at 38.89%. When measured over the past 30 days, the indicator reaches 19.32%. CERo Therapeutics Holdings Inc (NASDAQ:CERO)’s beta value is currently sitting at 0.08, while the Average True Range indicator is currently displaying 0.05.
To see how CERo Therapeutics Holdings Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: CERO stock’s performance was -1.13% at last check in today’s session, and -97.83% in the past year.
An evaluation of the daily trading volume of CERo Therapeutics Holdings Inc (NASDAQ:CERO) indicates that the 3-month average is 62.20 million. However, this figure has increased over the past 10 days to an average of 350.19.
Currently, records show that 51.35 million of the company’s shares remain outstanding. The insiders hold 19.87% of outstanding shares, whereas institutions hold 4.24%. The stats also highlight that short interest as of 2024-10-31, stood at 1.6 million shares, resulting in a short ratio of 0.29 at that time. From this, we can conclude that short interest is 208.00 of the company’s total outstanding shares. It is noteworthy that short shares in October were down slightly from the previous month’s figure, which was 2.32 million. However, since the stock’s price has seen -97.85% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
